Liver cancer drug trial halted early – only 13 patients enrolled
Disease control
Terminated
This study tested a weekly chemotherapy drug called Taxoprexin in people with advanced liver cancer that had not responded to other treatments. The goal was to see if the drug could shrink tumors and how safe it was. Only 13 people took part, and the trial was stopped early, so r…
Phase: PHASE2 • Sponsor: American Regent, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC